Post by
Kondero on Nov 27, 2014 10:52am
The last obstacles
Hard to understand ( impossible should I say ) what is really going on without being an outsider. But some good news can be seen forward : 1- décisions from Medicare and Medicaid about reimbursement.2- announcement concerning other partners for the GCC test.3- Outcomes about the new test (PCP). 4-The limit where the royalties from the PCA3 test will turn into 16% (when?). CUR' strategy? My feeling is that CUR wants to force Hologic's hand : Fradet made a test ( multi-markers) whose markers are perfectly compatible and complementary to the PCA3 gene. ( Is it for an enhanced sensibility? Is it for an optimum ability to detect at the earliest stage the aggressiveness of cancers? )... So that HOLX would be inevitably compelled to cooperate with CUR and then share its rights on the PCA3 gene. As for Bordeleau , if he succeeded to get a deal with the Chinese, I do'nt see why he would'nt do the same elsewhere. Fantomatus
Comment by
Kondero on Nov 29, 2014 10:25am
Erratum: in my previous post, first line, instead of 'outsider' please read 'insider' . Fantomatus